Amyloid-β and cognition in aging and Alzheimer's disease: Molecular and neurophysiological mechanisms

Journal of Alzheimer's Disease

Volumn 33, Issue SUPPL. 1, 2013, Pages

  Hampel, Harald ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; amyloid cascade hypothesis; amyloid ; asymptomatic; biomarkers; connectivity; CSF; default mode network; dementia; detection; diagnosis; dimers; DMN; fMRI; mild cognitive impairment; molecular mechanisms; network paradigm; neural networks; neurophysiology; oligomers; pathophysiology; preclinical; prodromal

Indexed keywords

AMYLOID BETA PROTEIN; FIBRILLAR COLLAGEN;

AGING; ALZHEIMER DISEASE; ASSOCIATIVE MEMORY; COGNITION; COGNITIVE DEFECT; EPISODIC MEMORY; HUMAN; IN VIVO STUDY; NERVE CELL NETWORK; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TASK PERFORMANCE;

EID: 84865455898     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-129003     Document Type: Review

References (72)

1. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185
2. Trojanowski JQ, HampelH(2011) Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention. Prog Neurobiol 95, 491-495
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746
4. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127
5. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269
6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279
7. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292
8. Herrup K (2010) Reimagining Alzheimer's disease-An agebased hypothesis. J Neurosci 30, 16755-16762
9. Schor NF (2011) What the halted phase III -Secretase inhibitor trial may (or may not) be telling us. Ann Neurol 69, 237-239
10. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639
11. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62, 925-931
12. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Aus'en B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langström B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319
13. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I,Wall A, Ringheim A, Langström B, Nordberg A (2006) Two-Year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129, 2856-2866
14. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ,Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging, Initiative (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355-1365
15. Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, Bullock R,Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ (2009) Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study. Neurology 73, 754-760
16. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59, 512-519
17. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) (11C)PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452
18. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45, 358-368
19. Pike KE, Ellis KA, Villemagne VL, Good N, Ch'etelat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC (2011) Cognition and beta-Amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia 49, 2384-2390
20. Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr (2012) APOE modifies the association between amyloid beta load and cognition in cognitively normal older adults. Neurology 78, 232-240
21. Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RA (2011) Face-Name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 49, 2776-2783
22. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65, 1509-1517
23. Villemagne VL, Pike KE, Ch'etelat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC (2011) Longitudinal assessment of Amyloid beta and cognition in aging and Alzheimer disease. Ann Neurol 69, 181-192
24. Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol 2, 605-613
25. Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, Tremont G, Alzheimer's Disease Neuroimaging, Initiative (2010) Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: Normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol 67, 688-696
26. Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M (2010) High-Molecularweight beta-Amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 24, 2716-2726
27. Santos AN, Ewers M, Minthon L, Simm A, Silber RE, Blennow K, Prvulovic D, Hansson O, Hampel H (2012) Amyloid- oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease. J Alzheimers Dis 29, 171-176
28. Klyubin I, Betts V, Welzel AT, Blennow K, Zetterberg H, Wallin A, Lemere CA, Cullen WK, Peng Y, Wisniewski T, Selkoe DJ, Anwyl R,Walsh DM, Rowan MJ (2008) Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: Prevention by systemic passive immunization. J Neurosci 28, 4231-4237
29. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-Term potentiation in vivo. Nature 416, 535-539
30. Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ (2005) Certain inhibitors of synthetic amyloid beta-Peptide (A beta) fibrillogenesis block oligomerization of natural A beta and thereby rescue long-Term potentiation. J Neurosci 25, 2455-2462
31. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25, 7709-7717
32. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 29, 1860-1873
33. Fox MD, Raichle ME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8, 700-711
34. Teipel SJ, Bokde AL, Meindl T, Amaro E Jr, Soldner J, Reiser MF, Herpertz SC,Möller HJ, Hampel H (2010) White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage 49, 2021-2032
35. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124, 1-38
36. Greicius MD, Supekar K, Menon V, Dougherty RF (2009) Resting-State functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex 19, 72-78
37. Wagner AD, Shannon BJ, Kahn I, Buckner RL (2005) Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci 9, 445-453
38. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-Mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A 101, 4637-4642
39. Sorg C, Riedl V, M?uhlau M, Calhoun VD, Eichele T, Láer L, Drzezga A, Förstl H, Kurz A, Zimmer C, Wohlschláger AM (2007) Selective changes of resting-State networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 104, 18760-18765
40. Allen G, Barnard H, McColl R, Hester AL, Fields JA,Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM (2007) Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol 64, 1482-1487
41. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, Wu T, Jiang T, Li K (2006) Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 31, 496-504
42. Wang K, Liang M, Wang L, Tian L, Zhang X, Li K, Jiang T (2007) Altered functional connectivity in early Alzheimer's disease: A resting-State fMRI study. Hum Brain Mapp 28, 967-978
43. Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T (2012) Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease. Neurobiol Aging 33, 466-478
44. Bokde AL, Lopez-Bayo P, Meindl T, Pechler S, Born C, Faltraco F, Teipel SJ, Möller HJ, Hampel H (2006) Functional connectivity of the fusiform gyrus during a face-Matching task in subjects with mild cognitive impairment. Brain 129, 1113-1124
45. FoxMD, Snyder AZ, Zacks JM, RaichleME(2006) Coherent spontaneous activity accounts for trial-To-Trial variability in human evoked brain responses. Nat Neurosci 9, 23-25
46. Weissman DH, Roberts KC, Visscher KM, Woldorff MG (2006) The neural bases of momentary lapses in attention. Nat Neurosci 9, 971-978
47. Hampson M, Driesen NR, Skudlarski P, Gore JC, Constable RT (2006) Brain connectivity related to working memory performance. J Neurosci 26, 13338-13343
48. Sambataro F, Murty VP, Callicott JH, Tan HY, Das S, Weinberger DR, Mattay VS (2010) Age-related alterations in default mode network: Impact on working memory performance. Neurobiol Aging 31, 839-852
49. Sala-Llonch R, Peña-G'omez C, Arenaza-Urquijo EM, Vidal-Piñeiro D, Bargall'o N, Junqu'e C, Bartr'es-Faz D (2011) Brain connectivity during resting state and subsequent working memory task predicts behavioural performance. Cortex, doi: 10.1016/j.cortex.2011.07.006
50. Daselaar SM, Prince SE, Dennis NA, Hayes SM, Kim H, Cabeza R (2009) Posterior midline and ventral parietal activity is associated with retrieval success and encoding failure. Front Hum Neurosci 3, 13
51. Huijbers W, Pennartz CM, Cabeza R, Daselaar SM (2011) The hippocampus is coupled with the default network during memory retrieval but not during memory encoding. PLoS One 6, e17463
52. Sperling RA, Laviolette PS,O'Keefe K, O'Brien J, RentzDM, Pihlajamaki M, Marshall G, HymanBT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178-188
53. Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ (2011) A deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex, doi: 10.1093/cercor/bhr255
54. Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RL (2009) Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 29, 12686-12694
55. Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM,Miller BL, Jagust WJ (2011) Relationships between beta-Amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex 21, 2399-2407
56. Kikuchi M, Hirosawa T, Yokokura M, Yagi S, Mori N, Yoshikawa E, Yoshihara Y, Sugihara G, Takebayashi K, Iwata Y, Suzuki K, Nakamura K, Ueki T, Minabe Y, Ouchi Y (2011) Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging. J Neurosci 31, 11193-11199
57. He J, Carmichael O, Fletcher E, Singh B, Iosif AM, Martinez O, Reed B, Yonelinas A, Decarli C (2012) Influence of functional connectivity and structural MRI measures on episodic memory. Neurobiol Aging, doi: 10.1016/j.neurobiolaging.2011.12.029
58. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA (2010) Spatial correlation between brain aerobic glycolysis and amyloid- (A) deposition. Proc Natl Acad Sci U S A 107, 17763-11777
59. Filippini N, MacIntosh BJ, HoughMG,GoodwinGM,Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 106, 7209-7214
60. Jagust WJ, Mormino EC (2011) Lifespan brain activity, -Amyloid, and Alzheimer's disease. Trends Cogn Sci 15, 520-526
61. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM,BuG, Mennerick S, HoltzmanDM(2008) Endocytosis is required for synaptic activity-Dependent release of amyloidbeta in vivo. Neuron 58, 42-51
62. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, MalinowR (2006)AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843
63. Puzzo D, Privitera L, Leznik E, F̀aM, Staniszewski A, Palmeri A, ArancioO(2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545
64. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711
65. Noebels J (2011) A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia 52, 39-46
66. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y (2006) Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47, 867-872
67. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580
68. Bokde AL, Ewers M, Hampel H (2009) Assessing neuronal networks: Understanding Alzheimer's disease. Prog Neurobiol 89, 125-133
69. Prvulovic D, Van de Ven V, Sack AT, Maurer K, Linden DE (2005) Functional activation imaging in aging and dementia. Psychiatry Res 140, 97-113
70. Prvulovic D, Bokde AL, Faltraco F, Hampel H (2011) Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Prog Neurobiol 95, 557-569
71. Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H (2011) Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 34, 430-442
72. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M,Winblad B, Coley N, Vellas B, Oxford Task Force Group (2011) Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol 95, 579-593